Catherine A. Sohn insider trades
Open-market stock purchases and sales by Catherine A. Sohn, Unknown at Altimmune, Inc, from SEC Form 4 filings since Aug 9, 2012.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -34%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 1, 2026 | ALT Altimmune, Inc | Bought (not open market) | — |
| Jan 7, 2026 | MAZE Maze Therapeutics, Inc | Bought (not open market) | — |
| Jan 7, 2026 | MAZE Maze Therapeutics, Inc | Bought (not open market) | — |
| Jan 7, 2026 | MAZE Maze Therapeutics, Inc | Bought (not open market) | — |
| Jan 7, 2026 | MAZE Maze Therapeutics, Inc | Sold | $1.1M |
| Jan 6, 2026 | MAZE Maze Therapeutics, Inc | Bought (not open market) | — |
| Jan 6, 2026 | MAZE Maze Therapeutics, Inc | Sold | $96.3K |
| Jan 5, 2026 | ALT Altimmune, Inc | Bought | $2.1K |
Companies traded
- ALT Altimmune, Inc: 2 buys, last May 1, 2026
- MAZE Maze Therapeutics, Inc: 2 sales, last Jan 7, 2026
- JAZZ Jazz Pharmaceuticals plc: 17 sales, last Aug 14, 2023
- LNDC Landec Corp \ca\: other filings, last Jun 4, 2022
- AXLA Axcella Health Inc: 1 buy, last May 19, 2022
- RUBY Rubius Therapeutics, Inc: 1 buy, last May 12, 2022
- CUR Neuralstem, Inc: other filings, last Jul 1, 2015